VIT — Vitura Health Income Statement
0.000.00%
- AU$47.02m
- AU$50.81m
- AU$124.04m
- 78
- 89
- 40
- 79
Annual income statement for Vitura Health, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
R2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21.7 | 67 | 117 | 124 | 124 |
Cost of Revenue | |||||
Gross Profit | 6.66 | 25.4 | 40.5 | 34.2 | 33.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 19.8 | 57.2 | 97.3 | 119 | 119 |
Operating Profit | 1.89 | 9.74 | 20.1 | 4.56 | 4.71 |
Net Income Before Taxes | 1.89 | 9.74 | 20.1 | 4.56 | 4.71 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.42 | 6.01 | 13.8 | 3.25 | 3.06 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.42 | 6.05 | 13.8 | 3.51 | 3.32 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.42 | 6.05 | 13.8 | 3.51 | 3.32 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.004 | 0.012 | 0.024 | 0.006 | 0.005 |
Dividends per Share |